Singapore (VNA) - Singapore will introduce an artificial intelligence (AI) assessment tool in early 2027 to help identify individuals at high risk of developing diabetes and high cholesterol – and move them to yearly cardiovascular disease risk screenings instead of once every three years.
Developed by the national health technology agency Synapxe, the Assisted Chronic Disease Explanation using AI tool analyses factors such as age and medical history to predict the likelihood of developing diabetes or hyperlipidemia.
Once deployed to primary care providers, those flagged as high risk will receive annual cardiovascular disease risk screenings, increased from the previous schedule of every three years. The screenings will be subsidised.
According to Singapore's Ministry of Health, individuals identified as high risk by the tool have more than a 75% chance of being diagnosed with diabetes, hyperlipidemia, or both within the next three years.
The ministry said the rollout represents "a shift towards digitally enabled preventive care," enabling targeted screenings based on individual risk profiles. /.
Singapore to train 100,000 AI-savvy workers by 2029
This ambition will be realised through the new National AI Impact Programme (NAIIP), which aims to train some 100,000 workers to be AI-savvy by 2029. Over the next three years, about 10,000 enterprises will also be equipped with AI capabilities.
